Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41


Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States.

Mahal BA, Catalano PJ, Haddad RI, Hanna GJ, Kass JI, Schoenfeld JD, Tishler RB, Margalit DN.

Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1660-1667. doi: 10.1158/1055-9965.EPI-19-0038. Epub 2019 Jul 29.


De-Escalation Strategies in HPV-Associated Oropharynx Cancer-Are we Putting the Cart Before the Horse?

Anderson CM, Kimple RJ, Lin A, Karam SD, Margalit DN, Chua MLK.

Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):705-709. doi: 10.1016/j.ijrobp.2019.02.054. No abstract available.


Two Sides of the Same Coin: Head and Neck Cancer Treatment De-Intensification and Intensification with Induction Chemotherapy.

Margalit DN, Lin A.

Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):1-4. doi: 10.1016/j.ijrobp.2018.04.002. Epub 2018 Aug 8. Review. No abstract available.


Modeling the Potential Benefits of Proton Therapy for Patients With Oropharyngeal Head and Neck Cancer.

Lester-Coll NH, Margalit DN.

Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):563-566. doi: 10.1016/j.ijrobp.2019.03.040. No abstract available.


A Phase 1 Study of Afatinib in Combination with Postoperative Radiation Therapy with and Without Weekly Docetaxel in Intermediate- and High-Risk Patients with Resected Squamous Cell Carcinoma of the Head and Neck.

Margalit DN, Haddad RI, Tishler RB, Chau NG, Schoenfeld JD, Bakst RL, Misiukiewicz KJ, Gupta V, Posner M, Hanna GJ, Mahmood U, Rawal B, Catalano PJ, Rath L, Bacay A, McHugh P, Rabinowits G.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):132-139. doi: 10.1016/j.ijrobp.2019.04.034. Epub 2019 May 11.


Everolimus in Anaplastic Thyroid Cancer: A Case Series.

Harris EJ, Hanna GJ, Chau N, Rabinowits G, Haddad R, Margalit DN, Schoenfeld J, Tishler RB, Barletta JA, Nehs M, Janne P, Huang J, Groden P, Kacew A, Lorch J.

Front Oncol. 2019 Feb 26;9:106. doi: 10.3389/fonc.2019.00106. eCollection 2019.


Outcomes following radiation for cutaneous squamous cell carcinoma of the head and neck: Associations between immune suppression and recurrence.

Arbab M, Margalit DN, Tishler RB, Rabinowits G, Pashtan IM, Borgelt BB, Powlis W, Holdsworth CH, Warren LE, Schoenfeld JD.

Head Neck. 2019 Jul;41(7):2111-2115. doi: 10.1002/hed.25663. Epub 2019 Jan 29.


IMRT-based treatment of unknown primary malignancy of the head and neck: Outcomes and improved toxicity with decreased mucosal dose and larynx sparing.

LaVigne AW, Margalit DN, Rawal B, Puzanov M, Annino DJ, Goguen LA, Sher DJ, Schoenfeld JD, Chau NG, Lorch JH, Rabinowits G, Haddad RI, Tishler RB.

Head Neck. 2019 Apr;41(4):959-966. doi: 10.1002/hed.25531. Epub 2019 Jan 8.


Evaluation of a community-based dental screening program prior to radiotherapy for head and neck cancer: a single-center experience.

Waring E, Mawardi H, Woo SB, Treister N, Margalit DN, Frustino J, Villa A.

Support Care Cancer. 2019 Sep;27(9):3331-3336. doi: 10.1007/s00520-018-4626-y. Epub 2019 Jan 7.


Radiation dose enhancement associated with contemporary dental materials.

Tso TV, Hurwitz M, Margalit DN, Lee SJ, Williams CL, Rosen EB.

J Prosthet Dent. 2019 Apr;121(4):703-707. doi: 10.1016/j.prosdent.2018.07.012. Epub 2018 Dec 21.


Funding Support and Principal Investigator Leadership of Oncology Clinical Trials Using Radiation Therapy.

Giacalone NJ, Milani N, Rawal B, Catalano PJ, Nguyen PL, Schoenfeld JD, Tishler RB, Margalit DN.

Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):34-43. doi: 10.1016/j.ijrobp.2018.05.037. Epub 2018 May 22.


Evaluating the PD-1 Axis and Immune Effector Cell Infiltration in Oropharyngeal Squamous Cell Carcinoma.

Schoenfeld JD, Gjini E, Rodig SJ, Tishler RB, Rawal B, Catalano PJ, Uppaluri R, Haddad RI, Hanna GJ, Chau NG, Rabinowits G, Lorch J, Jo VY, Krane JF, Goguen LA, Annino DJ, Abdelrahman S, Lipschitz M, Margalit DN.

Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):137-145. doi: 10.1016/j.ijrobp.2018.05.002. Epub 2018 Jun 29.


Treatment-refractory ALK-positive inflammatory myofibroblastic tumour of the oral cavity.

LaVigne AW, Meredith DM, D'Adamo DR, Margalit DN.

BMJ Case Rep. 2018 Apr 11;2018. pii: bcr-2017-221553. doi: 10.1136/bcr-2017-221553.


Palliative Head and Neck Cancer Treatment for Asymptomatic Disease.

Yerramilli D, Kovatch KJ, Chan AW, Swiecicki P, Margalit DN, Shuman AG.

Otolaryngol Head Neck Surg. 2018 Jul;159(1):25-28. doi: 10.1177/0194599818761861. Epub 2018 Feb 27. No abstract available.


Reirradiation for Head and Neck Cancer: The Who and the How.

Margalit DN, Wong SJ.

Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):618-620. doi: 10.1016/j.ijrobp.2017.12.279. No abstract available.


The Touchy Topic of the Touch Cell: A Case of Merkel Cell Carcinoma.

Margalit DN.

Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):12-13. doi: 10.1016/j.ijrobp.2017.08.008. No abstract available.


The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline.

Sultan A, Hanna GJ, Margalit DN, Chau N, Goguen LA, Marty FM, Rabinowits G, Schoenfeld JD, Sonis ST, Thomas T, Tishler RB, Treister NS, Villa A, Woo SB, Haddad R, Mawardi H.

Oncologist. 2017 Nov;22(11):1413. doi: 10.1634/theoncologist.2016-0298erratum. No abstract available.


Patient-oriented toxicity endpoints after head and neck reirradiation with intensity modulated radiation therapy.

Margalit DN, Schoenfeld JD, Rawal B, Haddad RI, Catalano PJ, Goguen LA, Chau NG, Rabinowits G, Lorch JH, Annino DJ, Tishler RB.

Oral Oncol. 2017 Oct;73:160-165. doi: 10.1016/j.oraloncology.2017.08.012. Epub 2017 Sep 8.


Comparative Analysis of MicroRNA Expression among Benign and Malignant Tongue Tissue and Plasma of Patients with Tongue Cancer.

Rabinowits G, Bowden M, Flores LM, Verselis S, Vergara V, Jo VY, Chau N, Lorch J, Hammerman PS, Thomas T, Goguen LA, Annino D, Schoenfeld JD, Margalit DN, Tishler RB, Haddad RI.

Front Oncol. 2017 Aug 29;7:191. doi: 10.3389/fonc.2017.00191. eCollection 2017.


Prospective analysis of radiation oncology image and plan-driven peer review for head and neck cancer.

Zairis S, Margalit DN, Royce TJ, Powlis WD, Tishler RB, Schoenfeld JD.

Head Neck. 2017 Aug;39(8):1603-1608. doi: 10.1002/hed.24800. Epub 2017 May 17.


Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma.

Hanna GJ, Sridharan V, Margalit DN, La Follette SK, Chau NG, Rabinowits G, Lorch JH, Haddad RI, Tishler RB, Anderson KS, Schoenfeld JD.

Cancer Biomark. 2017;19(2):129-136. doi: 10.3233/CBM-160071.


The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline.

Sultan A, Hanna GJ, Margalit DN, Chau N, Goguen LA, Marty FM, Rabinowits G, Schoenfeld JD, Sonis ST, Thomas T, Tishler RB, Treister NS, Villa A, Woo SB, Haddad R, Mawardi H.

Oncologist. 2017 Mar;22(3):343-350. doi: 10.1634/theoncologist.2016-0298. Epub 2017 Feb 16. Review. Erratum in: Oncologist. 2017 Nov;22(11):1413.


A comparative study of standard intensity-modulated radiotherapy and RapidArc planning techniques for ipsilateral and bilateral head and neck irradiation.

Pursley J, Damato AL, Czerminska MA, Margalit DN, Sher DJ, Tishler RB.

Med Dosim. 2017 Spring;42(1):31-36. doi: 10.1016/j.meddos.2016.10.004. Epub 2016 Dec 2.


Merkel Cell Carcinoma: A Population Analysis on Survival.

Sridharan V, Muralidhar V, Margalit DN, Tishler RB, DeCaprio JA, Thakuria M, Rabinowits G, Schoenfeld JD.

J Natl Compr Canc Netw. 2016 Oct;14(10):1247-1257.


Patterns of failure after reirradiation with intensity-modulated radiation therapy and the competing risk of out-of-field recurrences.

Margalit DN, Rawal B, Catalano PJ, Haddad RI, Goguen LA, Annino DJ, Limaye SA, Lorch JH, Lavigne AW, Schoenfeld JD, Sher DJ, Tishler RB.

Oral Oncol. 2016 Oct;61:19-26. doi: 10.1016/j.oraloncology.2016.07.012. Epub 2016 Aug 6.


Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer.

Sridharan V, Margalit DN, Lynch SA, Severgnini M, Zhou J, Chau NG, Rabinowits G, Lorch JH, Hammerman PS, Hodi FS, Haddad RI, Tishler RB, Schoenfeld JD.

Br J Cancer. 2016 Jul 12;115(2):252-60. doi: 10.1038/bjc.2016.166. Epub 2016 Jul 5.


Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patients.

Sridharan V, Margalit DN, Lynch SA, Severgnini M, Hodi FS, Haddad RI, Tishler RB, Schoenfeld JD.

J Immunother Cancer. 2016 Jun 21;4:32. doi: 10.1186/s40425-016-0138-9. eCollection 2016.


Population-based validation of the recursive partitioning analysis-based staging system for oropharyngeal cancer.

Keane FK, Chen YH, Tishler RB, Schoenfeld JD, Haddad RI, Goguen LA, Catalano P, Neville BA, Margalit DN.

Head Neck. 2016 Oct;38(10):1530-8. doi: 10.1002/hed.24470. Epub 2016 Apr 15.


Synchronous squamous cell carcinoma and diffuse large B-cell lymphoma of the head and neck: the odd couple.

Raldow AC, Brown JG, Chau N, Davids MS, Margalit DN, Tishler RB, Ng A, Schoenfeld JD.

BJR Case Rep. 2016 Jan 19;2(1):20150271. doi: 10.1259/bjrcr.20150271. eCollection 2016.


Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma.

Chau NG, Li YY, Jo VY, Rabinowits G, Lorch JH, Tishler RB, Margalit DN, Schoenfeld JD, Annino DJ, Goguen LA, Thomas T, Becker H, Haddad T, Krane JF, Lindeman NI, Shapiro GI, Haddad RI, Hammerman PS.

Clin Cancer Res. 2016 Jun 15;22(12):2939-49. doi: 10.1158/1078-0432.CCR-15-2314. Epub 2016 Jan 13.


Radiation Oncology--New Approaches in Squamous Cell Cancer of the Head and Neck.

Margalit DN, Schoenfeld JD, Tishler RB.

Hematol Oncol Clin North Am. 2015 Dec;29(6):1093-106. doi: 10.1016/j.hoc.2015.07.008. Review.


Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.

Keane FK, Chen YH, Neville BA, Tishler RB, Schoenfeld JD, Catalano PJ, Margalit DN.

Cancer. 2015 Aug 1;121(15):2594-602. doi: 10.1002/cncr.29402. Epub 2015 Apr 14.


GermLine Variation in Superoxide Dismutase-2 (SOD2) and Survival Outcomes After Radiation Therapy for Prostate Cancer: Results of a Test and Validation Set Analysis.

Margalit DN, Jordahl KM, Werner L, Wang X, Gwo-Shu Lee M, Penney KL, Batista JL, Martin NE, Chan JM, Kantoff PW, Stampfer MJ, Nguyen PL, Mucci LA.

Clin Genitourin Cancer. 2015 Aug;13(4):370-377.e1. doi: 10.1016/j.clgc.2014.12.018. Epub 2015 Jan 3.


Ensuring head and neck oncology patients receive recommended pretreatment dental evaluations.

Margalit DN, Losi SM, Tishler RB, Schoenfeld JD, Ann Fugazzotto J, Stephens J, Cebulski AL, Hammerstrand EL, Ma L, Lopes HM, Haddad RI, Treister NS, Frustino JL.

J Oncol Pract. 2015 Mar;11(2):151-4. doi: 10.1200/JOP.2014.000414. Epub 2015 Jan 27.


A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer.

Schoenfeld JD, Margalit DN, Kasperzyk JL, Shui IM, Rider JR, Epstein MM, Meisner A, Kenfield SA, Martin NE, Nguyen PL, Kantoff PW, Giovannucci EL, Stampfer MJ, Mucci LA.

Clin Cancer Res. 2013 Mar 15;19(6):1612-9. doi: 10.1158/1078-0432.CCR-12-2718. Epub 2013 Feb 4.


Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.

Margalit DN, Sreedhara M, Chen YH, Catalano PJ, Nguyen PL, Golshan M, Overmoyer BA, Harris JR, Brock JE.

Ann Surg Oncol. 2013 Mar;20(3):811-8. doi: 10.1245/s10434-012-2640-8. Epub 2012 Sep 7.


Active tobacco smoking and distant metastasis in patients with oropharyngeal cancer.

McBride SM, Ali NN, Margalit DN, Chan AW.

Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):183-8. doi: 10.1016/j.ijrobp.2011.11.044. Epub 2012 Feb 11.


Beta-carotene antioxidant use during radiation therapy and prostate cancer outcome in the Physicians' Health Study.

Margalit DN, Kasperzyk JL, Martin NE, Sesso HD, Gaziano JM, Ma J, Stampfer MJ, Mucci LA.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):28-32. doi: 10.1016/j.ijrobp.2011.05.032. Epub 2011 Nov 11.


Technological advancements and error rates in radiation therapy delivery.

Margalit DN, Chen YH, Catalano PJ, Heckman K, Vivenzio T, Nissen K, Wolfsberger LD, Cormack RA, Mauch P, Ng AK.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e673-9. doi: 10.1016/j.ijrobp.2011.04.036. Epub 2011 Jun 12.


Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older.

Margalit DN, Mamon HJ, Ancukiewicz M, Kobayashi W, Ryan DP, Blaszkowsky LS, Clark J, Willett CG, Hong TS.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e735-41. doi: 10.1016/j.ijrobp.2010.12.056. Epub 2011 Mar 4.


Targeting cell division: small-molecule inhibitors of FtsZ GTPase perturb cytokinetic ring assembly and induce bacterial lethality.

Margalit DN, Romberg L, Mets RB, Hebert AM, Mitchison TJ, Kirschner MW, RayChaudhuri D.

Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11821-6. Epub 2004 Aug 2. Erratum in: Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13969.

Supplemental Content

Loading ...
Support Center